Past Presentations
June 2019
- CREDENCE: Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation - Kenneth W. Mahaffey, MD
May 2019
- CREDENCE: Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation - Kenneth W. Mahaffey, MD
April 2019
- CREDENCE: Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation - Kenneth W. Mahaffey, MD
November 2017
- Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events in Type 2 Diabetes: Results From the CANVAS Program - Kenneth W. Mahaffey, MD
March 2017
- Time to Reboot Clinical Trials 2.0 - Kenneth W. Mahaffey, MD